With the joint launch of the SPD, the Andalusian Pharmacy aims to make an effective contribution to improving therapeutic adherence, which is one of the major challenges of the public health system, from a health and economic point of view.
It is estimated that therapeutic non-compliance in Andalusia affects 50% of patients with chronic treatments and 20% of acute patients. Of these patients, more than 360,000 are polymedicated and more than 36,000 take 5 medications daily. Lack of therapeutic adherence can affect up to a third of hospital admissions.
The conclusion, therefore, is that improving adherence to treatment constitutes, first, an improvement in the quality of life of patients, but also one of the best savings measures for the public health system.